Nominations open for FDA Impact Award 2021

There is lots of fantastic work going on and our Impact Award is our way of recognising that work and saying thank you.
You can nominate a member, representative or branch who you think has made a difference in one (or more) of the following areas:
- Campaign: where a campaign has been run in a local area resulting in engaging members and/or a win on an issue.
- Engagement: members have been engaged to become more involved in the FDA, with high participation in branch structures/surveys or regular successful events.
- Branch development: introducing new forms of communication, recruiting members to the committee, increasing branch activity.
- Recruitment: where a large number of new members have been recruited, declining membership has been reversed, or where members have been recruited from unengaged areas or despite challenging circumstances.
- Casework: where a significant win has been achieved, a win on a difficult case or a win on a case that has resulted in wider change in the department.
- Negotiation: where a win has been achieved for members through negotiations with the employer.
To nominate an outstanding member, workplace rep or branch please complete this form and return by email to amy@fda.org.uk by midday Monday 12th April.
Related News
-

“An outstanding leader with a proven track record” – FDA responds to Dame Antonia Romeo appointment
The FDA has welcomed the appointment of former Home Office Permanent Secretary Dame Antonia Romeo as Cabinet Secretary, following the departure of Sir Chris Wormald last week.
-

“New low” for government’s relationship with civil service – FDA responds following departure of Cabinet Secretary Chris Wormald
The FDA has responded to the announcement that Sir Chris Wormald has departed the role of Cabinet Secretary, with FDA General Secretary Dave Penman describing it as a “new low” for the government’s relationship with the civil service.
-

“Farcical” to wait until 2030 to make decision on restoration and renewal of parliament, says FDA
The FDA has responded to the latest publication of UK Parliament’s Restoration and Renewal Board, ‘Delivering restoration and renewal of the Palace of Westminster: the costed proposals.’